Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review.
about
Cholinesterase inhibitors for rarer dementias associated with neurological conditionsNatural Phytochemicals in the Treatment and Prevention of Dementia: An OverviewEffect of rivastigmine on mobility of patients with higher-level gait disorder: a pilot exploratory study.Comparison of the effects of transdermal and oral rivastigmine on cognitive function and EEG markers in patients with Alzheimer's disease.Single dose pharmacokinetics of the novel transdermal donepezil patch in healthy volunteersA 24-Week, Randomized, Controlled Study to Evaluate the Tolerability, Safety and Efficacy of 2 Different Titration Schemes of the Rivastigmine Patch in Japanese Patients with Mild to Moderate Alzheimer's DiseaseReal-world evaluation of compliance and preference in Alzheimer's disease treatment.Compliance and Caregiver Satisfaction in Alzheimer's Disease: Results from the AXEPT Study.Real-world evaluation of compliance and preference in Alzheimer's disease treatment: an observational study in Taiwan.Safety and tolerability of transdermal and oral rivastigmine in Alzheimer's disease and Parkinson's disease dementia.Reviews: Effects of transdermal rivastigmine on ADAS-cog items in mild-to-moderate Alzheimer's disease.Drug delivery strategies for Alzheimer's disease treatment.Transdermal patches for the treatment of neurologic conditions in elderly patients: a review.Transdermal rivastigmine in the treatment of Alzheimer's disease: current and future directions.Rivastigmine from capsules to patch: therapeutic advances in the management of Alzheimer's disease and Parkinson's disease dementia.The effect of vascular risk factors on the efficacy of rivastigmine patch and capsule treatment in Alzheimer's disease.Recent trends in the transdermal delivery of therapeutic agents used for the management of neurodegenerative diseases.Tyrosine-based rivastigmine-loaded organogels in the treatment of Alzheimer's disease.Transdermal donepezil on the treatment of Alzheimer's disease.An atypical cutaneous reaction to rivastigmine transdermal patchEvaluating rivastigmine in mild-to-moderate Parkinson's disease dementia using ADAS-cog items.Dose effects associated with rivastigmine transdermal patch in patients with mild-to-moderate Alzheimer's disease.Efficacy of higher dose 13.3 mg/24 h rivastigmine patch on instrumental activities of daily living in patients with mild-to-moderate Alzheimer's disease.A prospective study on the use of rivastigmine transdermal patch in Alzheimer’s dementia in a routine clinical setting.Pharmacokinetics of Memantine after a Single and Multiple Dose of Oral and Patch Administration in Rats.Electrosteric stealth Rivastigmine loaded liposomes for brain targeting: preparation, characterization, ex vivo, bio-distribution and in vivo pharmacokinetic studies.Absolute bioavailability and safety of a novel rivastigmine nasal spray in healthy elderly individuals.A pilot randomized controlled trial evaluating an integrated treatment of rivastigmine transdermal patch and cognitive stimulation in patients with Alzheimer's disease.Randomized, double-blind, parallel-group, 48-week study for efficacy and safety of a higher-dose rivastigmine patch (15 vs. 10 cm²) in Alzheimer's disease.Rivastigmine Patch in Chinese Patients with Probable Alzheimer's disease: A 24-week, Randomized, Double-Blind Parallel-Group Study Comparing Rivastigmine Patch (9.5 mg/24 h) with Capsule (6 mg Twice Daily).A 24-week, multicentre, open evaluation of the clinical effectiveness of the rivastigmine patch in patients with probable Alzheimer's disease.Efficacy of rivastigmine tartrate, transdermal system, in Alzheimer's disease.Comparative pharmacokinetics and safety assessment of transdermal berberine and dihydroberberine.Impact of transdermal drug delivery on treatment adherence in patients with Alzheimer’s diseaseStrategies for Continued Successful Treatment in Patients with Alzheimer’s Disease: An Overview of Switching Between Pharmacological Agents
P2860
Q24187428-0A6199D9-381A-45B7-B319-4027606F3037Q26750581-21C08D23-499A-49E8-8550-2D75E517861EQ33804754-08B434BF-A777-4662-AE62-531AA641E2FBQ33937187-D701916B-0615-42BA-9E3A-427CD276DD16Q35184995-784DB3B2-E15D-4E17-85BD-236851C0FDCBQ36261229-75D3B5E1-00BB-4E9D-B5A2-D56A5D86AC5FQ36264977-BF4866C8-364E-44DC-8C4E-35B7B2BCB219Q36383025-82F9E68A-F7C2-4E2B-83E1-9FB1FA89249BQ36766861-3687416C-77EF-4E11-9BE4-7A4F2E2655A0Q37658872-3D6404B0-8561-479C-B354-DAB6217F0B15Q37816073-BE5989F9-F055-4D5C-98EE-840D069B6FB3Q37851509-A87DB604-10F5-46B8-B36A-06168DA267BCQ37997774-3D3A3C28-C4A8-447B-9A1E-9F69E7307FFCQ38247181-78852728-1C4B-4B84-AFEC-13CA3B2A2756Q38350602-98C766A9-E522-47B4-AF46-25C79C20B58BQ38801735-94647CDC-2196-4913-B95F-274DD5BB6BABQ38972042-0F999E8B-BBCB-4172-B609-5E4D1E705D23Q39477637-7F4993FD-7E71-408E-81BB-178A31CF8C4CQ41786451-8260067E-E689-43B7-B621-6D384CE48AC0Q42577896-0EDE58FF-B02D-41F6-9E2B-F28210B1FE0CQ43099287-9848436D-F6A6-41DB-8395-12FC763AE161Q43609548-384BF255-6119-4A96-B705-4C02CBEA272DQ44542466-3F7BCD1C-B888-4C41-96EC-A8DC5F418AD7Q45756592-231C2B7D-DF9A-4824-A9BE-DBCC84382A6DQ46373585-DC4EBA8F-7B66-4635-89F1-035B39FBC1C9Q46526710-7AF5A216-E476-471C-ACBC-3A3AFD9DABF6Q47801349-F1166112-F4EC-406B-962C-69E4B667CD58Q48152841-7352A5BB-BD66-4200-B61F-7CF96B566CCDQ48439989-F9335264-1B21-48ED-A638-3E636DCECAF7Q50536127-5C5B8AAB-7463-4387-962A-7686365A3A0EQ50799612-28FD236D-BF24-4AA4-BD31-C4251EEFBCEBQ51491144-F71B5EF5-643D-483F-884A-2CA0C5EB680CQ55071906-1B1A3FD6-1027-4ECD-8882-7EADE8426F6FQ57814526-2EF4BD28-A5EB-4F61-A927-A103E95A74AFQ58794595-7160F4A5-E26D-449B-B0D0-11D22B8D8529
P2860
Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pharmacokinetics of a novel tr ...... Alzheimer's disease: a review.
@en
Pharmacokinetics of a novel tr ...... Alzheimer's disease: a review.
@nl
type
label
Pharmacokinetics of a novel tr ...... Alzheimer's disease: a review.
@en
Pharmacokinetics of a novel tr ...... Alzheimer's disease: a review.
@nl
prefLabel
Pharmacokinetics of a novel tr ...... Alzheimer's disease: a review.
@en
Pharmacokinetics of a novel tr ...... Alzheimer's disease: a review.
@nl
P2093
P2860
P921
P1476
Pharmacokinetics of a novel tr ...... Alzheimer's disease: a review.
@en
P2093
P2860
P304
P356
10.1111/J.1742-1241.2009.02052.X
P5008
P577
2009-05-01T00:00:00Z